Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women
- PMID: 11836196
- DOI: 10.1093/aje/155.4.323
Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women
Abstract
The authors investigated the dose-effect relation between alcohol drinking and hepatocellular carcinoma (HCC) in men and women separately, also considering hepatitis B and hepatitis C virus infections. They enrolled 464 subjects (380 men) with a first diagnosis of HCC as cases and 824 subjects (686 men) unaffected by hepatic diseases as controls; all were hospitalized in Brescia, northern Italy, in 1995-2000. Spline regression models showed a steady linear increase in the odds ratio of HCC for increasing alcohol intake, for values of >60 g of ethanol per day, with no substantial differences between men and women. Duration of drinking and age at start had no effect on the odds ratio when alcohol intake was considered. Former drinkers who had stopped 1-10 years previously had a higher risk of HCC than current drinkers did. The effect of alcohol drinking was evident even in the absence of hepatitis B or hepatitis C virus infection. In addition, a synergism between alcohol drinking and either infection was found, with approximately a twofold increase in the odds ratio for each hepatitis virus infection for drinkers of >60 g per day.
Similar articles
-
Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study.Int J Cancer. 1999 May 31;81(5):695-9. doi: 10.1002/(sici)1097-0215(19990531)81:53.0.co;2-w. Int J Cancer. 1999. PMID: 10328218
-
Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):213-6. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10698484
-
[To investigate the relationship of alcohol intake and hepatocellular carcinoma among patients with hepatitis B virus infection].Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Oct;25(5):328-30. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011. PMID: 22338215 Chinese.
-
Risk factors of hepatocellular carcinoma--current status and perspectives.Asian Pac J Cancer Prev. 2012;13(3):743-52. doi: 10.7314/apjcp.2012.13.3.743. Asian Pac J Cancer Prev. 2012. PMID: 22631642 Review.
-
Hepatitis C virus and hepatocellular carcinoma.Curr Stud Hematol Blood Transfus. 1994;(61):98-120. doi: 10.1159/000423271. Curr Stud Hematol Blood Transfus. 1994. PMID: 7525158 Review. No abstract available.
Cited by
-
Association of Alcohol Use and Physical Activity with Body Mass Index in Mexican-Origin Adults.J Racial Ethn Health Disparities. 2022 Jun;9(3):812-819. doi: 10.1007/s40615-021-01019-2. Epub 2021 Mar 15. J Racial Ethn Health Disparities. 2022. PMID: 33721292 Free PMC article.
-
Alcoholic hepatitis and HCV interactions in the modulation of liver disease.J Viral Hepat. 2015 Oct;22(10):769-76. doi: 10.1111/jvh.12399. Epub 2015 Mar 6. J Viral Hepat. 2015. PMID: 25754333 Free PMC article. Review.
-
Ambovex(®) as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial.J Hepatocell Carcinoma. 2015 Jun 22;2:79-89. doi: 10.2147/JHC.S60864. eCollection 2015. J Hepatocell Carcinoma. 2015. PMID: 27508197 Free PMC article.
-
Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region.Gut Liver. 2016 May 23;10(3):332-9. doi: 10.5009/gnl15257. Gut Liver. 2016. PMID: 27114433 Free PMC article. Review.
-
Non-viral causes of hepatocellular carcinoma.World J Gastroenterol. 2010 Aug 7;16(29):3603-15. doi: 10.3748/wjg.v16.i29.3603. World J Gastroenterol. 2010. PMID: 20677332 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical